B. Camitta

R. Larson, P. Gaynon, P. McCarthy, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Thyroid carcinoma following treatment for acute lymphoblastic leukemia

S. Duck, B. Camitta, J. Holcenberg, 1980, Cancer.

Providing personalized prognostic information for adult leukemia survivors.

Alan M. Miller, B. Storer, B. George, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mycobacterium avium intracellulare Infection Coexistent With Nodular Lymphocyte Predominant Hodgkin Lymphoma Involving the Lung

A. Rao, P. Havens, C. Cogbill, 2011, Journal of pediatric hematology/oncology.

Intensified PEG-L-asparaginase and Antimetabolite-based Therapy for Treatment of Higher Risk Precursor-B Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

J. Shuster, J. Kurtzberg, M. Devidas, 2007, Journal of pediatric hematology/oncology.

Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.

H. Deeg, E. Guinan, B. George, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

A. Zander, M. Horowitz, J. Liesveld, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.

V. Brown, R. Gale, S. Gadalla, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: A Pediatric Oncology Group study (now The Children's Oncology Group)

J. Shuster, B. Bostrom, B. Camitta, 2004, Pediatric blood & cancer.

Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.

J. Shuster, J. Kurtzberg, M. Devidas, 2007, Blood.

Great oaks from little acorns

B. Camitta, 2004 .

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE

S. Grupp, N. Ueno, R. Gale, 2013, Bone Marrow Transplantation.

Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children.

M. Amylon, Y. Ravindranath, J. Pullen, 1997, Blood.

Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.

C. Pui, N. Heerema, L. Silverman, 2007, Blood.

Children's perceptions of their sibling's death at home or hospital: the precursors of differential adjustment.

R. Mulhern, B. Camitta, M. Lauer, 1985, Cancer nursing.

Home care for dying children: a nursing model.

B. Camitta, M. Lauer, B. Camitta, 1980, The Journal of pediatrics.

A comparison study of parental adaptation following a child's death at home or in the hospital.

R. Mulhern, B. Camitta, M. Lauer, 1983, Pediatrics.

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood

J. Krischer, J. Graham-Pole, A. Carroll, 1996 .

Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407

S. Hunger, M. Devidas, N. Winick, 2012, Pediatric blood & cancer.

Pathogenesis and Treatment of Acute Lymphocytic Leukemia in Infants

B. Camitta, 2004 .

A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia.

R. Storb, R. Gale, K. Kopecky, 1979, Blood.

Nephroblastoma (Wilms tumor): tubule density and prognosis.

S. McCreadie, B. Camitta, T. T. Tang, 1978, Medical and pediatric oncology.

Recent approaches to the treatment of acute lymphocytic leukemia in childhood.

B. Camitta, J. Holcenberg, 1981, Annual review of pharmacology and toxicology.

Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients.

D. Nathan, B. Camitta, J. Rappeport, 1978, Blood.

Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.

M. Horowitz, N. Flomenberg, L. Baxter‐Lowe, 1994, Blood.

N. Flomenberg, L. Baxter‐Lowe, D. Margolis, 1996, British journal of haematology.

Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphocytic leukemia.

B. Camitta, C. L. Kien, 1987, JPEN. Journal of parenteral and enteral nutrition.

Increased whole-body protein turnover in sick children with newly diagnosed leukemia or lymphoma.

B. Camitta, C. L. Kien, 1983, Cancer research.

Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

R. Storb, R. Gale, D. Nathan, 1976, Blood.

Anemia in adolescence. 1. Disturbances of iron balance.

D. Nathan, B. Camitta, 1975, Postgraduate medicine.

Failure of early intensive chemotherapy to improve prognosis in childhood acute lymphocytic leukemia.

B. Camitta, D. Pinkel, L. Kun, 1980, Medical and pediatric oncology.

Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): addition of an anthracycline to vincristine and prednisone.

S. Sallan, B. Camitta, E. Frei, 1977, Medical and pediatric oncology.

Hepatopathy following irradiation and adriamycin

B. Camitta, L. Kun, 1978, Cancer.

Partially matched bone marrow transplantation in patients with myelodysplastic syndromes.

R. Truitt, B. Camitta, N. Bunin, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PEDIATRIC BONE MARROW TRANSPLANTATION-A BIO-ETHICAL MODEL

W. Curran, D. Nathan, B. Camitta, 1974, Pediatric Research.

Cerebral toxoplasmosis in an immunocompromised host. A precise and rapid diagnosis by electron microscopy.

R. Wells, W. Dunne, M. Chusid, 1986, American journal of clinical pathology.

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma

S. Davies, H. Lazarus, P. Stiff, 2008, Bone Marrow Transplantation.

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

H. Schrezenmeier, G. Socié, E. Gluckman, 2006, Bone Marrow Transplantation.

Childhood A cute L ymphoblastic L eukemia W ith t he MLL-ENL Fusion a nd t (11;19)(q23;p13 .3) T ranslocation

J. Downing, F. Behm, S. Raimondi, 1999 .

CELL WALL COMPOSITION AND VIRULENCE IN ESCHERICHIA COLI

B. Camitta, D. Medearis, E. Heath, 1968, The Journal of experimental medicine.

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

J. Sierra, J. Dipersio, S. Tarima, 2010, Blood.

Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children.

M. Amylon, Y. Ravindranath, J. Pullen, 1997, Blood.

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

B. Sandmaier, M. Aljurf, R. Gale, 2016, Cancer.

Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review.

P. Gaynon, P. McCarthy, M. Pulsipher, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Szer, B. George, R. Gale, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.

J. Krischer, J. Graham-Pole, Y. Ravindranath, 1996, The New England journal of medicine.

Dental management of patients undergoing bone marrow transplantation for aplastic anemia.

B. Camitta, H. Needleman, S. Lasser, 1977, Oral surgery, oral medicine, and oral pathology.

The role of irradiation in central nervous system treatment and prophylaxis for acute lymphoblastic leukemia

A. Dritschilo, J. Cassady, B. Camitta, 1976, Cancer.

Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia

G. Rosner, D. Murry, S. Lunagomez, 2007, Cancer Chemotherapy and Pharmacology.

Reply to A. Bleyer et al

Xiaomin Lu, S. Hunger, M. Devidas, 2012 .

Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T‐cell leukemia

R. G. Hoffman, R. Krance, B. Camitta, 1987, Cancer.

Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation.

R. Mulhern, R. Kline, B. Camitta, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy for Initial Induction Failures in Childhood Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study (POG 8764)

B. Pollock, M. Devidas, B. Camitta, 2013, Journal of pediatric hematology/oncology.

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

J. Downing, K. Dobbin, C. Mullighan, 2010, Blood.

Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation.

P. Newburger, M. Chusid, B. Camitta, 1980, The American journal of medicine.

Rearrangement of CRLF 2 is associated with mutation of JAK kinases , alteration of IKZF 1 , Hispanic / Latino ethnicity , and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia *

J. Downing, K. Dobbin, C. Mullighan, 2010 .

Desacetyl vinblastine amide sulfate induced ineffective erythropoiesis

B. Camitta, J. Holcenberg, B. Camitta, 1979, Cancer.

Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure.

H. Deeg, J. Wagner, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

RISK FACTORS AFFECTING OUTCOME OF SECOND HLA-MATCHED SIBLING DONOR TRANSPLANTS FOR GRAFT FAILURE IN SEVERE ACQUIRED APLASTIC ANEMIA

S. Tarima, R. Gale, J. Passweg, 2009 .

Prognostic Significance of Minimal Residual Disease (MRD) in Children with High Risk Acute Lymphoblastic Leukemia(ALL) A Children’s Oncology Group Study.

M. Borowitz, M. Devidas, J. Pullen, 2005 .

Safety of delayed leucovorin "rescue" following high-dose methotrexate in children.

B. Camitta, J. Holcenberg, 1978, Medical and pediatric oncology.

Caregiving Demands and Well-being in Parents of Children Treated With Outpatient or Inpatient Methotrexate Infusion: A Report From the Children’s Oncology Group

P. Hinds, B. Camitta, K. Kelly, 2014, Journal of pediatric hematology/oncology.

Biology-Driven Classification of Childhood Acute Lymphoblastic Leukemia: A Combined Analysis of Prognostic Markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG).

J. Shuster, N. Heerema, H. Sather, 2004 .

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review.

R. Larson, P. Gaynon, P. McCarthy, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results.

Rimm, A. Rimm, M. Horowitz, 1989, Blood.

Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.

A. Rimm, M. Horowitz, R. Gale, 1992, Blood.

Selection of patients for bone marrow transplantation in severe aplastic anemia.

D. Nathan, B. Camitta, J. Rappeport, 1975, Blood.

The role of viral infections in aplastic anemia.

B. Camitta, 1979, Haematology and blood transfusion.

Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation.

D. Nathan, B. Camitta, J. Rappeport, 1974, Blood.

Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study.

J. Graham-Pole, R. Marcus, B. Camitta, 1988, Bone marrow transplantation.

Biology and treatment of acute lymphocytic leukemia in children.

J. Pullen, B. Camitta, S. Murphy, 1997, Seminars in oncology.

Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival.

James, Rimm, K., 1989, Blood.

Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation

M. Horowitz, N. Flomenberg, D. Margolis, 1997, Bone Marrow Transplantation.

Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

A. Look, M. Borowitz, A. Carroll, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia

M. Horowitz, L. Baxter‐Lowe, B. Camitta, 1994 .

What Is the Definition of Cure for Aplastic Anemia?

B. Camitta, 2000, Acta Haematologica.

A Randomized Comparative Study of Purged Autologous Bone Marrow Transplantation Versus Intensive Multiagent Consolidation Chemotherapy in First Remission of Acute Myeloid Leukemia in Children (Pediatric Oncology Group Study—POG 8821)

S. Raimondi, J. Graham-Pole, A. Carroll, 1997 .

Imatinib resistant BCR‐ABL1 mutations at relapse in children with Ph+ALL: a Children's Oncology Group (COG) study

B. Druker, S. Hunger, N. Winick, 2012, British journal of haematology.

Treatment of recurrent CNS disease post‐bone marrow transplant in familial HLH

B. Camitta, J. Talano, H. Rangarajan, 2012, Pediatric blood & cancer.

T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin’s lymphoma: clinical and molecular follow-up

M. Hessner, M. Horowitz, D. Vesole, 1998, Bone Marrow Transplantation.

Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.

A. Rimm, M. Horowitz, R. Gale, 1992, Blood.

Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse: A Children's Oncology Group Study (POG 8866)

B. Pollock, J. Kurtzberg, M. Bernstein, 2011, Journal of pediatric hematology/oncology.

Use of irradiated lymphocytes from immune donors for treatment of disseminated varicella.

R. J. Starshak, M. Chusid, B. Camitta, 1994, The Journal of pediatrics.

Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis.

R. Storb, B. Camitta, E. Thomas, 1982 .

Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial.

R. Truitt, B. Camitta, V. Piaskowski, 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study.

J. Downing, F. Behm, C. Pui, 1997, Blood.

Absidia corymbifera endocarditis: survival after treatment of disseminated mucormycosis with radical resection of tricuspid valve and right ventricular free wall.

P. Havens, M. Mitchell, B. Camitta, 2010, The Journal of thoracic and cardiovascular surgery.

HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens.

J. Wagner, M. Pasquini, Richard E. Harris, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The surgeon's role in pediatric orbital malignancies: an oncologist's perspective.

B. Camitta, M. Browning, 2003, Ophthalmic plastic and reconstructive surgery.

Acute erythroid hypoplasia in malnourished Infant sq uirrel mo nkeys fed isolated soy

D. Gallina, B. Camitta, L. Ausman, 1977 .

CELL WALL COMPOSITION AND VIRULENCE I N ESCHERICHIA COLI*,

B. Camitta, E. Heath, 2003 .

Bone marrow transplantation for severe aplastic anemia: has outcome improved?

J. Klein, M. Horowitz, R. Gale, 1997, Blood.

Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia.

R. Storb, R. Hoffmann, R. Gale, 1983, Blood.

Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update

R. Gelber, D. Rosenthal, R. Mayer, 1983 .

Prognostic value of antibody-dependent assays for presensitization in bone marrow transplant recipients.

F. Rosen, B. Camitta, J. Rappeport, 1978, Transplantation proceedings.

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

J. Klein, M. Horowitz, J. Passweg, 2007, Blood.

Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research.

M. Devidas, W. Carroll, E. Raetz, 2005, Blood.

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

C. Pui, W. Kamps, A. Baruchel, 2002, The Lancet.

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.

C. Pui, W. Kamps, A. Baruchel, 2000, The New England journal of medicine.

Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings.

B. Camitta, K. Murray, J. Casper, 1989, Blood.

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

J. Klein, M. Tallman, A. Keating, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of acute myelogenous leukemia in children and adults.

D. Rosenthal, R. Mayer, D. Nathan, 1980, The New England journal of medicine.

Pathogenesis and treatment of aplastic anemia.

B. Camitta, 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.

J. Wagner, J. Kurtzberg, M. Horowitz, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathogenesis of severe aplastic anemia: inferences from therapeutic trials.

B. Camitta, 1979, Haematology and blood transfusion.

Primary cerebral germinoma and ventriculoperitoneal shunt metastasis

B. Camitta, L. Kun, J. Sty, 1981, Cancer.

Severe aplastic anaemia: a prospective study of the effect of androgens or transplantation on haematological recovery and survival.

B. Camitta, E. Thomas, 1978, Clinics in haematology.

Dose Intensification of Methotrexate and Cytarabine During Intensified Continuation Chemotherapy for High-risk B-Precursor Acute Lymphoblastic Leukemia: POG 9406 A Report From the Children’s Oncology Group

J. Shuster, J. Kurtzberg, M. Devidas, 2014, Journal of pediatric hematology/oncology.

Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].

S. Hunger, M. Borowitz, M. Devidas, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential Oral Hydroxyurea and Intravenous Cytosine Arabinoside in Refractory Childhood Acute Leukemia: A Pediatric Oncology Group Phase 1 Study

Y. Ravindranath, B. Camitta, D. Mahoney, 2008, Journal of pediatric hematology/oncology.

Intensive sequential chemotherapy for children with acute myelogenous leukemia.

R. Gelber, M. Link, H. Weinstein, 1990, Haematology and blood transfusion.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Alan M. Miller, R. Vij, F. Baron, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.

J. Klein, R. Gale, J. Passweg, 2007, Blood.

lymphoblastic leukemia: a report from the Children's Oncology Group Key pathways are frequently mutated in high-risk childhood acute

Michael N. Edmonson, J. Downing, M. Relling, 2013 .

Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Michael N. Edmonson, M. Loh, J. Downing, 2011, Blood.

Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.

Cheng Cheng, Dario Campana, Paul Scheet, 2012, Blood.

Outcomes after induction failure in childhood acute lymphoblastic leukemia.

C. Pui, A. Baruchel, L. Silverman, 2012, The New England journal of medicine.

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).

S. Lipshultz, M. Borowitz, M. Devidas, 2011, Blood.

Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study.

J. Shuster, C. Civin, B. Camitta, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

M. Loh, J. Shuster, N. Heerema, 2007, Blood.

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements

C. Pui, N. Heerema, A. Baruchel, 2003, Leukemia.

Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.

J. Downing, F. Behm, S. Raimondi, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive Alternating Drug Pairs After Remission Induction for Treatment of Infants With Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Pilot Study

J. Shuster, A. Carroll, J. Pullen, 1998, Journal of pediatric hematology/oncology.

Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study

M. Borowitz, J. Rubnitz, B. Camitta, 1998, Leukemia.

Outcome of Children with Standard‐Risk T‐Lineage Acute Lymphoblastic Leukemia—Comparison among Different Treatment Strategies

J. Gastier-Foster, N. Heerema, S. Hunger, 2016, Pediatric blood & cancer.

Accumulation of High Levels of Methotrexate Polyglutamates in Lymphoblasts From Children With Hyperdiploid ( > 50 chromosomes ) B-Lineage Acute Lymphoblastic Leukemia : A Pediatric Oncology Group Study

J. Shuster, A. Carroll, B. Camitta, 2003 .

Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study.

J. Shuster, B. Camitta, D. Mahoney, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial.

N. Winick, B. Camitta, R. Nitschke, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B—lineage acute lymphoblastic leukemia. A pediatric oncology group pilot study

J. Shuster, B. Camitta, B. Leventhal, 1995, Cancer.

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

J. Shuster, B. Pollock, A. Rimm, 1994, The New England journal of medicine.

Intensive alternating drug pairs for treatment of high‐risk childhood acute lymphoblastic leukemia. A pediatric oncology group pilot study

J. Shuster, C. Civin, J. Pullen, 1993, Cancer.

Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404.

S. Lipshultz, M. Borowitz, M. Devidas, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children

B. Camitta, A. Segura, H. Oechler, 1990, Cancer.

Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia.

S. Davies, P. Mehta, M. Ayas, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The treatment of acute myelogenous leukemia in children and adults: VAPA update.

R. Gelber, D. Rosenthal, R. Mayer, 1983, Haematology and blood transfusion.

New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases.

J. Shuster, M. Amylon, M. Link, 2000, Blood.

Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103.

L. Gordon, M. Horowitz, C. Link, 1998, Human gene therapy.

Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma.

M. Relling, C. Pui, G. Reaman, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant U rate O xidase f or t he P rophylaxis o r Treatment o f H yperuricemia i n P atients W ith L eukemia or L ymphoma

M. Relling, C. Pui, G. Reaman, 2001 .

High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study.

J. Shuster, H. Friedman, D. Wall, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optic chiasm glioma associated with inappropriate secretion of antidiuretic hormone, cerebral ischemia, nonobstructive hydrocephalus and chronic ascites following ventriculoperitoneal shunting

B. Camitta, H. Whelan, D. Strother, 1991, Child's Nervous System.

Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

M. Loh, M. Relling, Cheng Cheng, 2013, Nature Genetics.

Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906

J. Shuster, S. Hunger, C. Willman, 2011, Pediatric blood & cancer.

pediatric B-progenitor acute lymphoblastic leukemia , Hispanic / Latino ethnicity , and a poor outcome in IKZF 1 alteration of kinases , JAK is associated with mutation of CRLF 2 Rearrangement of

J. Downing, K. Dobbin, C. Mullighan, 2010 .

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.

J. Downing, E. Bedrick, C. Mullighan, 2010, Blood.

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

S. Hunger, C. Willman, M. Borowitz, 2008, Blood.

Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update.

R. Gelber, D. Rosenthal, R. Mayer, 1983, Blood.

Allergic Reactions to E. coli L-Asparaginase Do Not Affect Outcome in Childhood B-precursor Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

J. Shuster, J. Kurtzberg, J. Pullen, 2007, Journal of pediatric hematology/oncology.

Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders

B. Trost, R. Orentas, B. Camitta, 2004, Bone Marrow Transplantation.

Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.

M. Loh, M. Relling, Cheng Cheng, 2013, Journal of the National Cancer Institute.

Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.

J. Shuster, D. Johnston, M. Devidas, 2007, Cancer genetics and cytogenetics.

INTENSIVE POST-REMISSION INDUCTION CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN CHILDREN AND ADULTS

R. Gelber, D. Rosenthal, R. Mayer, 1984 .

Plasma Methotrexate, Red Blood Cell Methotrexate, and Red Blood Cell Folate Values and Outcome in Children With Precursor B-acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Xiaomin Lu, J. Shuster, M. Devidas, 2012, Journal of pediatric hematology/oncology.

Abnormalities of Lymphatic Vessels

B. Camitta, R. Tower, 2011 .

Minimal residual disease detection in childhood precursor–B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study

J J Shuster, J. Shuster, C. Willman, 2003, Leukemia.

Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3)

F. Behm, N. Heerema, C. Felix, 2015, Pediatric blood & cancer.

Prognostic factors in childhood acute myelogenous leukemia.

R. Gelber, K. Price, M. Link, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

pediatric B-precursor acute lymphoblastic leukemia residual disease improve risk classification and outcome prediction in Gene expression classifiers for relapse-free survival and minimal

J. Downing, E. Bedrick, C. Mullighan, 2010 .

Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.

F. Behm, N. Heerema, W. Woods, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis.

Allen R. Chen, M. Horowitz, R. Gale, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

J. Shuster, M. DeBaun, B. Pollock, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

A. Look, J. Shuster, Y. Ravindranath, 1998, Leukemia & lymphoma.

Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome.

J. Kurtzberg, M. Cairo, M. Pulsipher, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

L. Baxter‐Lowe, B. Camitta, N. Bunin, 1995, Blood.

Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.

S. Davies, M. Cairo, B. Camitta, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma.

D. Blaise, R. Gale, R. Childs, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study.

J. Krischer, B. Camitta, J. Boyett, 1991, Journal of neurosurgery.

Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome

J. Kurtzberg, M. Cairo, M. Pulsipher, 2014, Pediatric blood & cancer.

Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

A. Look, B. Camitta, L. Cooley, 2005, Leukemia.

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.

J. Klein, M. Horowitz, R. Gale, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow transplantation for an infant with neutrophil dysfunction.

T. Stossel, J. Cassady, D. Nathan, 1977, Experimental hematology.

Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis.

R. Storb, B. Camitta, E. Thomas, 1982, The New England journal of medicine.

Effectiveness of a six‐drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children

B. Camitta, L. Kun, J. Casper, 1985, Cancer.

Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse.

B. Camitta, V. Piaskowski, J. Casper, 1982, Leukemia research.

Childhood primary cutaneous non‐T/non‐B lymphoma followed by acute T‐cell leukemia

B. Camitta, S. Lauer, T. T. Tang, 1986, Cancer.

Splenic Torsion in an Infant Associated with Secondary Disseminated Hemophilus influenzae Infection

B. Camitta, K. Kelly, Michael J. Chusid, 1982, La Clinica pediatrica.

Acute erythroid hypoplasia in malnourished infant squirrel monkeys fed isolated soy protein.

D. Gallina, B. Camitta, D. Hegsted, 1977, American Journal of Clinical Nutrition.

DETECTION OF GENETICALLY DETERMINED HISTOCOMPATIBILITY ANTIGEN DIFFERENCES BETWEEN HL‐A IDENTICAL AND MLC NONREACTIVE SIBLINGS

F. Rosen, B. Camitta, J. Rappeport, 1976, Transplantation.

Allogeneic bone marrow transplants for Fanconi anemia. A preliminary report from the International Bone Marrow Transplant Registry.

W. Friedrich, R. Good, R. Champlin, 1992, Bone Marrow Transplantation.

Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study.

M. Amylon, B. Camitta, G. Rivera, 1986, The New England journal of medicine.

Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor.

B. Camitta, A. Zeevi, R. Duquesnoy, 1983, Transplantation.

Antithoracic duct lymphocyte globulin.

D. Nathan, B. Camitta, R. O'reilly, 1983, Blood.

Acute lymphoidic leukemia in a patient with thrombocytopenia/absent radii (Tar) syndrome.

B. Camitta, A. Rock, 1993, The American journal of pediatric hematology/oncology.

Anemia in adolescence. 2. Hemoglobinopathies and other causes.

D. Nathan, B. Camitta, 1975, Postgraduate medicine.

controlled study of conditioning regimens Bone marrow transplantation for severe aplastic anemia: a randomized

J. Klein, M. Horowitz, J. Passweg, 2013 .

Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.

B. George, R. Gale, H. Lazarus, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chemotherapy with cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) in childhood acute lymphoblastic leukemia (ALL).

S. Sallan, B. Camitta, N. Jaffe, 1977, Medical and pediatric oncology.

Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia.

S. Tarima, R. Gale, J. Passweg, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Terminal transferase surveillance of remission bone marrows in childhood acute lymphoblastic leukemia: improved sensitivity with countercurrent centrifugal elutriation.

B. Camitta, S. Lyman, J. Casper, 1985, Journal of clinical & laboratory immunology.

Neutropenia in dysgammaglobulinemia I: remission with immunoglobulin therapy.

S. E. Adair, M. Chusid, B. Camitta, 1981, Wisconsin medical journal.

relapse and survival Marrow transplantation for acute lymphoblastic leukemia: factors affecting

M. Horowitz, R. Good, E. Gluckman, 2011 .

The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft‐versus‐host disease in paediatric patients

R. Punzalan, B. Camitta, H. Rangarajan, 2013, British journal of haematology.

Congenital neutropenia: Studies of pathogenesis

P. Tomasulo, M. Chusid, B. Camitta, 1980, American journal of hematology.

Cyclic neutropenia in identical twins.

S. McCreadie, M. Chusid, B. Camitta, 1986, The American journal of medicine.

Hla antigens and haplotypes in 200 patients with aplastic anemia.

R. Storb, E. Albert, B. Camitta, 1976, Transplantation.

Successful treatment of recurrent CNS disease post‐bone marrow transplant in children with familial hemophagocytic lymphohistiocytosis

B. Camitta, J. Talano, Allison M Bock, 2016, Pediatric blood & cancer.

Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia.

S. Davies, B. Logan, B. Camitta, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myelofibrosis-myeloid metaplasia in childhood.

L. Boxer, B. Camitta, W. Berenberg, 1975, Pediatrics.

A.L.G. IN APLASTIC ANÆMIA

B. Camitta, 1978, The Lancet.

CRITERIA FOR SEVERE APLASTIC ANAEMIA

E. Montserrat, B. Camitta, C. Rozman, 1988, The Lancet.

Comparison o f P reparative R egimens i n T ransplants f or Children W ith A cute L ymphoblastic L eukemia

J. Klein, M. Horowitz, R. Gale, 2000 .

Optimizing Use of the Complete Blood Count

B. Camitta, Bruce M. Camitta, Rebecca Jean Slye, 2012 .

ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.

M. Loh, M. Relling, Cheng Cheng, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children’s Oncology Group Studies P9904 and P9905

J. Shuster, S. Hunger, C. Willman, 2019, Leukemia.

Long‐term follow‐up of parental adjustment following a child's death at home or hospital

R. Mulhern, M. Schell, B. Camitta, 1989, Cancer.

The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

A. Look, B. Camitta, L. Cooley, 2001, Leukemia.

Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.

A. Look, J. Shuster, M. Bernstein, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings.

B. Camitta, N. Bunin, K. Murray, 1992, Bone marrow transplantation.

Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study.

A. Look, M. Borowitz, A. Carroll, 1997, Blood.

Racial D ifferences i n t he S urvival o f C hildhood B - Precursor A cute L ymphoblastic L eukemia: A P ediatric Oncology G roup S tudy

J. Shuster, M. DeBaun, B. Pollock, 2000 .

Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders.

J. Southern, B. Camitta, E. Baselga, 2001, Archives of dermatology.

Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipients.

M. Horowitz, L. Baxter‐Lowe, B. Camitta, 1995, Transplantation proceedings.

Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study.

B. Camitta, B. Leventhal, D. Strother, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multilocular renal cyst: electron microscopic evidence of pathogenesis.

B. Camitta, H. Oechler, T. T. Tang, 1984, The American journal of pediatric hematology/oncology.

Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: A prospective longitudinal study

D. Margolis, B. Camitta, M. J. Kupst, 2002, Bone Marrow Transplantation.

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission

J. Klein, R. Gale, M. Trigg, 2002, British journal of haematology.

Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research

J. Szer, M. Tallman, K. Ballen, 2013, Haematologica.

Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.

S. Hunger, M. Borowitz, M. Devidas, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved Early Event Free Survival (EFS) in Children with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Intensive Imatinib in Combination with High Dose Chemotherapy: Children’s Oncology Group (COG) Study AALL0031.

N. Heerema, H. Sather, S. Hunger, 2007 .

Collaborative study of marrow transplantation for sickle cell disease: Aspects specific for transplantation of hemoglobin disorders

K. Sullivan, R. Storb, W. Leisenring, 1997 .

C. Anasetti, E. Gluckman, B. Camitta, 1992, Bone marrow transplantation.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

M. Norkin, B. Sandmaier, B. George, 2019, Blood advances.

Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party

N. Young, J. Passweg, A. Tichelli, 2010, British journal of haematology.

Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results.

B. Camitta, K. Doney, 1990, The American journal of pediatric hematology/oncology.

S. Davies, B. Camitta, N. Kapoor, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. ASBMT Position Statement.

P. Gaynon, P. McCarthy, M. Pulsipher, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Antithoracic duct lymphocyte globulin [letter]

D. Nathan, B. Camitta, R. O'reilly, 1983 .

Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL

D. Margolis, B. Camitta, M. Eapen, 2006, Bone Marrow Transplantation.

Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.

M. Horowitz, N. Flomenberg, B. Camitta, 1995, Bone marrow transplantation.

Glucocorticoid resistance: a persistent riddle

B. Camitta, 2006 .

Utilization of hospice/home care in pediatric oncology A national survey

R. Mulhern, R. Hoffmann, B. Camitta, 1986, Cancer Nursing.

Patterns of communication among pediatric patients with leukemia, parents, and physicians: prognostic disagreements and misunderstandings.

R. Mulhern, B. Camitta, J. Crisco, 1981, The Journal of pediatrics.

Human pharmacology and toxicology of succinylated Acinetobacter glutaminase-asparaginase.

B. Ring, B. Camitta, J. Holcenberg, 1979, Cancer research.

Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia

S. Raimondi, James R. Anderson, W. Sanger, 2007, Genes, chromosomes & cancer.

PharmGKB Update: II. CYP3A5, Cytochrome P450, Family 3, Subfamily A, Polypeptide 5

E. Cook, M. Boguski, F. Behm, 2004, Pharmacological Reviews.

Role of Methotrexate in the Treatment of Acute Lymphoblastic Leukemia

B. Camitta, B. Kamen, 2003 .

Identification of leukemic cells in the cerebrospinal fluid from children with acute lymphoblastic leukemia: advances and dilemmas.

B. Camitta, S. Lauer, P. Kirchner, 1989, The American journal of pediatric hematology/oncology.

Evaluation of cerebrospinal fluid mononuclear cells obtained from children with acute lymphocytic leukemia: advantages of combining cytomorphology and terminal deoxynucleotidyl transferase.

B. Camitta, J. Casper, S. Lauer, 1983, American journal of clinical pathology.

Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.

C. Pui, J. Shuster, J. Kurtzberg, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Doxorubicin cardiomyopathy in children with left-sided Wilms tumor.

B. Camitta, D. Pinkel, L. Kun, 1982, Medical and pediatric oncology.

Children ' s Cancer Group lymphoblastic leukemia : a combined analysis of prognostic markers Risk-and response-based classification of childhood B-precursor acute

Stephen P. Hunger, Jeffrey E. Rubnitz, Jonathan J. Shuster, 2007 .

Prognostic Factors and Patterns of Failure in Childhood Acute Myeloid Leukemia: Experience on Pediatric Oncology Group Study # 8821

S. Raimondi, A. Carroll, Y. Ravindranath, 2001 .

Predictive of Treatment Outcome in Childhood Acute Lymphoblastic Chimeric Transcript Status at End of Consolidation Is Not E 2 A-PBX

J. Shuster, S. Hunger, M. Link, 1998 .

Cardioprotection and safety of dexrazoxane (DRZ) in children treated for newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) or advanced stage lymphoblastic leukemia (T-LL).

T. Zhou, S. Lipshultz, M. Devidas, 2012 .

Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs.

B. Monia, N. Dean, M. Diccianni, 2002, Leukemia research.

A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL).

R. Veroff, E. Bedrick, P. Helman, 2005 .

Increasing incidence of adenovirus disease in bone marrow transplant recipients.

M. Horowitz, B. Camitta, N. Bunin, 1994, The Journal of infectious diseases.

Nelarabine Can Be Safely Incorporated into an Intensive, Multiagent Chemotherapy Regimen for the Treatment of T-Cell Acute Lymphocytic Leukemia (ALL) in Children: A Report of the Children’s Oncology Group (COG) AALL00P2 Protocol for T-Cell Leukemia.

S. Hunger, M. Borowitz, M. Devidas, 2006 .

Outcomes after HLA-Matched Sibling Transplants or Chemotherapy in Children with Acute Lymphoblastic Leukemia in a Second Remission after an Isolated Central Nervous System Relapse.

S. Grupp, M. Devidas, W. Carroll, 2006 .

Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study

A. Look, J. Shuster, M. Amylon, 1999, Leukemia.

Effect of abrupt discontinuation of high glucose infusion rates during parenteral nutrition.

S. Werlin, B. Camitta, D. Wyatt, 1994, The Journal of pediatrics.

Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.

J. Shuster, D. Cheo, M. Borowitz, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

M. Tallman, O. Ringdén, R. Martino, 2004, Bone Marrow Transplantation.

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

J. V. Stone, J. Klein, J. Wingard, 1999 .

Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.

B. Camitta, B. Kamen, J. Holcenberg, 1986, Cancer treatment reports.

Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.

R. Truitt, L. Baxter‐Lowe, B. Camitta, 1990, The New England journal of medicine.

Setting up a pediatric oncology program in Cambodia: successes and challenges

L. Kean, S. Howard, I. Qaddoumi, 2017 .

Does intraveneous 6‐mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia?

M. Devidas, B. Camitta, Donald H. Mahoney, 2006 .

Hematopoietic stem cell transplant (HSCT) versus intensive chemotherapy in infant acute lymphoblastic leukemia (ALL)

N. Heerema, M. Devidas, G. Reaman, 2007 .

Changes in the Delivery of Standard Chemotherapeutic Agents during Induction Affect Early Measures of Minimal Residual Disease (MRD): POG 9900 for Patients with B-Precursor Low and Standard Risk ALL.

S. Hunger, M. Borowitz, N. Winick, 2006 .

Hepatic ultrastructure in leukemic children treated with methotrexate and 6‐mercaptopurine

S. Werlin, B. Camitta, B. Kamen, 1983, The American journal of pediatric hematology/oncology.

Anatomy and Function of the Spleen

B. Camitta, A. Brandow, 2011 .

KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study.

F. Behm, N. Heerema, C. Felix, 2023, Haematologica.

Prognostic Significance of Minimal Residual Disease (MRD) in Childhood B-Precursor ALL and Its Relation to Other Risk Factors. A Children’s Oncology Group (COG) Study.

S. Hunger, C. Willman, M. Borowitz, 2006 .